Literature DB >> 8726929

Relationships between radiological pattern and cell-mediated immune response in Mycoplasma pneumoniae pneumonia.

H Tanaka1, H Koba, S Honma, F Sugaya, S Abe.   

Abstract

The aim of this study was to determine the relationship between the radiological pattern of Mycoplasma pneumoniae and the level of cell-mediated immunity of the host. Computed tomographic (CT) scans of the chest and the results of the purified protein derivative (PPD) test were studied during the acute stage of infection in 54 patients with M. pneumoniae pneumonia. The CT findings were used to divide the patients into two groups: one group had a predominance of nodular opacities with a centrilobular distribution (Group N; n = 29); and the other showed a predominance of an airspace consolidation (Group C; n = 25). Forty out of 54 subjects had negative tuberculin skin tests ( < 10 mm induration). The positive rate of PPD reaction was higher in Group N (13 out of 29) compared to Group C (1 out of 25) (p = 0.0005); whilst pleural effusion appeared more frequently in Group C (10 out of 25) than in Group N (3 out of 29) (p = 0.023). There was no significant difference between Groups N and C in white blood cell and lymphocyte counts, level of antibodies to M. pneumoniae in sera, and severity of the disease. These findings suggest that the characteristics of the host cell-mediated immunity might influence the pattern of pulmonary lesions in M. pneumoniae infection.

Entities:  

Mesh:

Year:  1996        PMID: 8726929     DOI: 10.1183/09031936.96.09040669

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection.

Authors:  M Narita; H Tanaka; S Yamada; S Abe; T Ariga; Y Sakiyama
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype.

Authors:  Anna C Nilsson; Per Björkman; Christina Welinder-Olsson; Anders Widell; Kenneth Persson
Journal:  BMC Infect Dis       Date:  2010-02-25       Impact factor: 3.090

3.  Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.

Authors:  M Narita; H Tanaka; S Abe; S Yamada; M Kubota; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 4.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia.

Authors:  You-Sook Youn; Kyung-Yil Lee; Ja-Young Hwang; Jung-Woo Rhim; Jin-Han Kang; Joon-Sung Lee; Ji-Chang Kim
Journal:  BMC Pediatr       Date:  2010-07-06       Impact factor: 2.125

6.  The efficacy of glucocorticoid on macrolide resistant Mycoplasma pneumonia in children.

Authors:  Jae-Won Oh
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-23       Impact factor: 5.764

7.  Role of IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae.

Authors:  Satoshi Kurata; Takako Osaki; Hideo Yonezawa; Ken Arae; Haruhiko Taguchi; Shigeru Kamiya
Journal:  BMC Microbiol       Date:  2014-06-13       Impact factor: 3.605

Review 8.  Correlation between Radiological and Pathological Findings in Patients with Mycoplasma pneumoniae Pneumonia.

Authors:  Hiroshi Tanaka
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

9.  Dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of Legionnaires' disease.

Authors:  Cornelis P C de Jager; Eugenie F A Gemen; Jacqueline Leuvenink; Mirrian Hilbink; Robert J F Laheij; Tom van der Poll; Peter C Wever
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

Review 10.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.